Effects of Low-Dose Fractionated Total Body Irradiation on Murine Immune System

마우스에서 전신 저선량 분할 방사선 조사에 의한 면역학적 변화 평가

  • Kim, Mi-Hyoung (Division of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences) ;
  • Rhu, Sang-Young (Departments of Obstetrics and Gynecology, Korea Cancer Canter Hospital, Korea Institute of Radiological & Medical Sciences) ;
  • Lim, Dae-Seog (Department of Biotechnology, CHA university) ;
  • Song, Jie-Young (Division of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences)
  • 김미형 (한국원자력의학원 방사선의학연구소 방사선암연구부) ;
  • 유상영 (한국원자력의학원 원자력병원 산부의과) ;
  • 임대석 (차의과학대학교 생명과학대학 바이오공학과) ;
  • 송지영 (한국원자력의학원 방사선의학연구소 방사선암연구부)
  • Received : 2014.07.08
  • Accepted : 2014.08.10
  • Published : 2014.09.30


Along with the wide use of radiotherapy in cancer treatment, there is growing interest in beneficial effect of low-dose irradiation (LDI) in cancer therapy. Therefore, we investigate how LDI affects immune responses in mice model. Total body irradiation (TBI) on C57BL/6 mice was given at low-dose rate of $1mGy{\cdot}min^{-1}$ using $^{137}Cs$ source at three times for consecutive three days. Hematological examination, total cell numbers of spleen, populations and characteristics of splenocytes were determined. Total numbers of RBC or platelet in irradiated mice showed no significant changes. WBC counts were decreased in a dose-dependent manner 2 days after TBI, however, these differences are gradually waned until 28 days. Dose-dependent decrease in the number of splenocytes of TBI mice at day 2 was also improved as time progressed. While the level of Foxp3 mRNA was decreased, the frequency of $CD4^+$ T cells and $CD69^+$ cells in spleen was increased at day 2 and 14. Fractionated low-dose TBI on mice exhibited normal body weight with no distinguishable behavior during whole experimental periods. These results suggest that some parameters of immune system could be altered and evaluated by fractionated low-dose TBI and be used to broaden boundary of low dose radiation research.


Supported by : 지식경제부


  1. Hall EJ, Giaccia AJ. Radiobiology for the Radiobiologist. 5th ed. New York; Lippincott Williams and Wilkins, 2000.
  2. Center for Drug Evaluation and Research (CDER). Guidance for industry, estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers, U.S. Department of Health and Human Services, Food and Drug Administration. Pharmacology and Toxicology. 2005.
  3. Williams JP, Brown SL, Georges GE, et al. Animal models for medical countermeasures to radiation exposure. Radiat. Res. 2010;173(4):557-578.
  4. Macklis RM. Radithor and the era of mild radium therapy. JAMA. 1990;264(5):614-618.
  5. Sowby FD. International commission on radiological protection: 1978 Stockholm meeting. Radiology. 1978;129(2):533-535.
  6. Calabrese EJ. Origin of the linearity no threshold (LNT) dose-response concept. Arch. Toxicol. 2013;87(9):1621-1633.
  7. Liu SZ, Jin SZ, Liu XD. Radiation-induced bystander effect in immune response. Biomed. Environ. Sci. 2004;17(1):40-46.
  8. Otsuka K, Koana T, Tomita M, et al. Rapid myeloid recovery as a possible mechanism of whole-body radioadaptive response. Radiat. Res. 2008;170(3):307-315.
  9. Liu SZ. Radiation hormesis. A new concept in radiological science. Chin. Med. J. (Engl). 1989;102(10):750-755.
  10. Prekeges JL. Radiation hormesis, or, could all that radiation be good for us? J. Nucl. Med. Technol. 2003;31(1):11-17.
  11. Safwat A. The immunobiology of low-dose total-body irradiation: More questions than answers. Radiat. Res. 2000;153(5 Pt 1):599-604.[0599:TIOLDT]2.0.CO;2
  12. Tubiana M, Feinendegen LE, Yang C, et al. The linear no-threshold relationship is inconsistent with radiation biologic and experimental data. Radiology. 2009;251(1):13-22.
  13. Doss M. Shifting the paradigm in radiation safety. Dose Response. 2012;10(4):562-583.
  14. Doss M. Linear no-threshold model vs. radiation hormesis. Dose Response. 2013;11:480-497.
  15. Morgan WF, Bair WJ. Issues in low dose radiation biology: The controversy continues. A perspective. Radiat. Res. 2013;179(5):501-510.
  16. ICRP. The 2007 recommendations of the international commission on radiological protection. ICRP publication 103. Ann ICRP. 2007;37(2-4):1-332.
  17. Rubner Y, Wunderlich R, Ruhle PF, et al. How does ionizing irradiation contribute to the induction of anti-tumor immunity? Front. Oncol. 2012;2:75.
  18. Farooque A, Mathur R, Verma A, et al. Low-dose radiation therapy of cancer: role of immune enhancement. Expert Rev. Anticanc. 2011;11(5):791-802.
  19. Fourquet A, Teillaud JL, Lando D, et al. Effects of low dose total body irradiation (LDTBI) and recombinant human interleukin-2 in mice. Radiother. Oncol. 1993;26(3):219-225.
  20. United Nations. Biological mechanisms of radiation actions at low doses. 1-2. New York. 2012.
  21. Suzuki K and Yamashita S. Low-dose radiation exposure and carcinogenesis. Jpn. J. Clin. Oncol. 2012;42(7):563-568.
  22. Son YH, Jung DH, Kim SD, et al. Dose and dose rate effects of irradiation on blood count and cytokine level in BALB/c mice. J. Radiation Protection. 2013;38(4):179-184.
  23. Shin SC, Lee KM, Kang YM, et al. Alteration of cytokine profiles in mice exposed to chronic low-dose ionizing radiation. Biochem. Bioph. Res. Co. 2010; 397(4):644-649.
  24. Gridley DS, Pecaut MJ, Dutta-Roy R, et al. Dose and dose rate effects of whole-body proton irradiation on leukocyte populations and lymphoid organs: part I. Immunol. Lett. 2002;80(1):55-66.
  25. Pecaut MJ, Gridley DS, Smith AL, et al. Dose and dose rate effects of whole-body proton-irradiation on lymphocyte blastogenesis and hematological variables: part II. Immunol. Lett. 2002;80(1):67-73.
  26. Ge Q, Hu H, Eisen HN, et al. Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments. P. Natl. Acad. Sci. USA. 2002;99(5): 2989-2994.
  27. Min B, Paul WE. Endogenous proliferation: burst-like CD4 T cell proliferation in lymphopenic settings. Semin. Immunol. 2005;17(3):201-207.
  28. Prlic M, Blazar BR, Khoruts A, et al. Homeostatic expansion occurs independently of costimulatory signals. J. Immunol. 2001;167(10):5664-5668.
  29. Maine GN, Mule JJ. Making room for T cells. J. Clin. Invest. 2002;110(2):157-159.
  30. Graca L. New tools to identify regulatory T cells. Eur. J. Immunol. 2005;35:1678-1680.
  31. Ohkura N, Sakaguchi S. Regulatory T cells: roles of T cell receptor for their development and function. Semin. Immunopathol. 2010;32(2):95-106.
  32. Gridley DS, Rizvi A, Luo-Owen X, et al. Low dose, low dose rate photon radiation modifies leukocyte distribution and gene expression in CD4(+) T cells. J. Radiat. Res. 2009;50(2):139-150.
  33. Bogdandi EN, Balogh A, Felgyinszki N, et al. Effects of low-dose radiation on the immune system of mice after total-body irradiation. Radiat. Res. 2010;174(4):480-489.
  34. Liu R, Xiong S, Zhang L, et al. Enhancement of antitumor immunity by low-dose total body irradiation is associated with selectively decreasing the proportion and number of T regulatory cells. Cell. Mol. Immunol. 2010;7(2):157-162.

Cited by

  1. Prediction of Midline Dose from Entrance and Exit Dose Using OSLD Measurements for Total Body Irradiation vol.42, pp.2, 2017,